BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2025 5:49:33 AM | Browse: 74 | Download: 147
 |
Received |
|
2025-04-28 11:39 |
 |
Peer-Review Started |
|
2025-04-28 11:39 |
 |
First Decision by Editorial Office Director |
|
2025-05-15 12:18 |
 |
Return for Revision |
|
2025-05-15 12:18 |
 |
Revised |
|
2025-05-27 02:24 |
 |
Publication Fee Transferred |
|
2025-05-29 10:35 |
 |
Second Decision by Editor |
|
2025-07-01 02:35 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-07-01 07:24 |
 |
Articles in Press |
|
2025-07-01 07:24 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-08-01 01:32 |
 |
Publish the Manuscript Online |
|
2025-08-14 05:49 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Risk prediction of acute variceal bleeding in hepatocellular carcinoma patients undergoing systemic therapy based on immune checkpoint inhibitors
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xu Zhang, Li-Meng Song, Yu-Piao Zheng, Bao-Xin Qian, Jing Liang and Feng-Mei Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Tianjin Key Medical Discipline (Specialty) Construction Project |
TJYXZDXK-034A |
| Hebei Province 2025 Traditional Chinese Medicine Scientific Research Project Plan |
T2025008 |
|
| Corresponding Author |
Feng-Mei Wang, PhD, Professor, First Central Hospital of Tianjin Medical University, Tianjin Medical University, Tianjin First Center Hospital, No. 2 Baoshan West Road, Xiyingmen Street, Xiqing District, Tianjin 300380, China. wangfengmeitj@126.com |
| Key Words |
Acute variceal bleeding; Hepatocellular carcinoma; Immune checkpoint inhibitors; Tyrosine kinase inhibitors; Variceal bleeding history; Risk factors |
| Core Tip |
Hepatocellular carcinoma patients with a history of variceal bleeding, tumor diameter ≥ 5 cm, portal vein tumor thrombosis, or elevated fibrosis-4 index (≥ 4.57) are at significantly increase the risk of recurrent variceal bleeding during immune checkpoint inhibitor (ICI)-based systemic therapy. Closely monitor these individuals for early signs of bleeding. Prior to initiating ICIs, consider endoscopic screening in high-risk patients. |
| Publish Date |
2025-08-14 05:49 |
| Citation |
Zhang X, Song LM, Zheng YP, Qian BX, Liang J, Wang FM. Risk prediction of acute variceal bleeding in hepatocellular carcinoma patients undergoing systemic therapy based on immune checkpoint inhibitors. World J Gastrointest Oncol 2025; 17(8): 108887 |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i8/108887.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i8.108887 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345